Device
Disparities in Reporting and Representation by Sex, Race, and Ethnicity in Endovascular Aortic Device Trials
J Vasc Surg. 2022 May 24:S0741-5214(22)01590-7. doi: 10.1016/j.jvs.2022.05.003. Online ahead of print.
ABSTRACT
OBJECTIVE: Vulnerable populations i...
Exactech Announces FDA Breakthrough Device Designation for JointMedica's Polymotion® Hip Resurfacing System
[May 17, 2022]
Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery...
Market Pathways - Racial Equity Increasing in Device Trials, But Reporting Remains Low
ARTICLE SUMMARY:
A look at the reported racial composition of device clinical trials is a good news/bad news situation: the inclusion of minority p...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
